Difficulty: Medium
Average Score: 73%
Practice
A 35-year-old G1P0 woman presents to her primary care physician at 35 weeks gestation with headaches. Her blood pressure is 164/90 mm Hg, although 6 months ago it was 124/74 mm Hg. She has no proteinuria and no edema. Which of the following antihypertensive would be best for this patient?
Correct answer
D
Rationale
In the case of a pregnant woman presenting with hypertension at 35 weeks gestation, the most appropriate antihypertensive medication is Methyldopa (Option D). Methyldopa is considered a first-line agent for the treatment of hypertension in pregnancy due to its well-established safety profile for both the mother and the fetus. It has been extensively studied and shown to effectively lower blood pressure without negatively impacting fetal development or causing adverse outcomes.
Atenolol (Option A) is contraindicated in pregnancy due to its association with fetal growth restriction and other adverse effects on the fetus. Lisinopril (Option B) and Losartan (Option C) are both contraindicated in pregnancy as they can cause severe harm to the developing fetus, including renal abnormalities and even fetal death.
For educational context, it is crucial for healthcare providers to be well-informed about the appropriate management of hypertension in pregnancy to ensure the safety and well-being of both the mother and the baby. Understanding the specific considerations and contraindications of antihypertensive medications in pregnancy is essential to making informed clinical decisions and providing optimal care to pregnant patients. Education on the use of safe and effective medications like Methyldopa in pregnancy can help prevent complications and improve outcomes for both mother and child.
Atenolol (Option A) is contraindicated in pregnancy due to its association with fetal growth restriction and other adverse effects on the fetus. Lisinopril (Option B) and Losartan (Option C) are both contraindicated in pregnancy as they can cause severe harm to the developing fetus, including renal abnormalities and even fetal death.
For educational context, it is crucial for healthcare providers to be well-informed about the appropriate management of hypertension in pregnancy to ensure the safety and well-being of both the mother and the baby. Understanding the specific considerations and contraindications of antihypertensive medications in pregnancy is essential to making informed clinical decisions and providing optimal care to pregnant patients. Education on the use of safe and effective medications like Methyldopa in pregnancy can help prevent complications and improve outcomes for both mother and child.